UBE3B通过对抗HIF-2α降解来促进乳腺癌的进展
Yijie Wang1, Xiong Liu2, Min Wang1
1Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, Institute of Biomedical Science, College of Life Sciences, Shandong Normal University, Jinan, Shandong, 250014, China.
Oncogene
|October 2, 2023
概括
E3酶UBE3B针对HIF-2α进行无处不在,抑制其降解并促进乳腺癌的生长. UBE3B上调与瘤中的HIF-2α相关,揭示了一种新的癌症机制.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 在E3泛基因酶UBE3B中的突变与考夫曼眼脑面综合征 (KOS) 相关.
- 新出现的证据表明,UBE3B在癌症发展中起着重要作用.
- 在癌症中UBE3B的特定功能和机制在很大程度上是未知的.
研究的目的:
- 阐明UBE3B在癌症中的作用.
- 调查UBE3B影响癌症进展的机制.
- 确定UBE3B作为癌症治疗中的潜在治疗标.
主要方法:
- 研究了UBE3B和缺氧诱导因子2α (HIF-2α) 之间的相互作用.
- 在实验室中评估UBE3B枯竭对乳腺癌细胞增殖,迁移和入侵的影响.
- 评估了UBE3B对瘤生长和体内转移的影响.
- 在HIF-2α上使用突变分析确定了关键的泛位.
主要成果:
- UBE3B 作为 HIF-2α 的 E3 连接酶,促进其 K63 结合的多比基因化.
- UBE3B 抑制了由 VHL E3 酶复合体介导的 HIF-2α 降解.
- 耗尽UBE3B抑制了乳腺癌细胞的增殖,迁移,入侵,瘤生长和肺转移.
- 在HIF-2α上的特定氨酸残留物 (K394,K497,K503) 被确定为UBE3B介导调节的关键.
- 发现UBE3B和HIF-2α蛋白水平在乳腺癌组织中受到上调和正相关.
结论:
- UBE3B在调节HIF-2α的稳定性和功能方面发挥着至关重要的作用.
- UBE3B通过HIF-2α稳定促进乳腺癌的进展和转移.
- UBE3B-HIF-2α轴代表了乳腺癌治疗的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


